Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findingsStefan Kubicka, Christophe Borg, Javier Sastre et al.|Annals of Oncology|2013Cited by 104
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOXJean‐François Emile, Yves Humblet, Catherine Julié et al.|European Journal of Cancer|2017Cited by 47